The purpose of this bill is to narrow the scope of prior authorization mandates for FDA approved antipsychotics.
2026/02/18 Markup Discussion
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | WV HB5482 | 0 | 20.25 | 12-02-2026 |
| 2 | WV HB5493 | 0 | 12.45 | 13-02-2026 |
| 3 | WV SB404 | 0 | 9.6 | 16-02-2026 |
| 4 | WV HB5103 | 0 | 22.04 | 10-02-2026 |
| 5 | WV HB5058 | 0 | 9.79 | 10-02-2026 |
| 6 | WV HB4403 | 0 | 13.77 | 18-02-2026 |
| 7 | WV HB4459 | 0 | 17.17 | 18-02-2026 |
| 8 | WV HB5476 | 0 | 10.39 | 19-02-2026 |
| 9 | WV HB5681 | 0 | 13.05 | 23-02-2026 |
| 10 | WV SB956 | 0 | 16.04 | 05-03-2026 |